<html>

<head>
    <meta name="viewport" content="width=1024, height=768, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="format-detection" content="telephone=no">
    <meta name="apple-mobile-web-app-capable" content="yes">
    <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">

    <title>iCVA Navigator</title>
    <!-- Global CSS -->
    <link href="../shared/css/reset.css" type="text/css" rel="stylesheet" media="all" />
    <link href="../shared/css/fonts.css" type="text/css" rel="stylesheet" media="all" />
    <link href="../shared/css/global_traning.css" type="text/css" rel="stylesheet" media="all" />
    <!-- Page level CSS -->
    <link href="./css/style.css" type="text/css" rel="stylesheet" />

    <!-- Global JS -->
    <script type="text/javascript" src="../shared/js/jquery.3.4.1.min.js"></script>

    <!-- Veeva JS -->
    <script type="text/javascript" src="../shared/js/veeva_js/veeva-library.js"></script>
    <script type="text/javascript" src="../shared/js/veeva_js/veeva_tranning.js"></script>

    <script type="text/javascript" src="../shared/js/custom_svg_icons.js"></script>
    <script type="text/javascript" src="../shared/js/global_traning.js"></script>
    <!-- <script type="text/javascript" src="../shared/js/globalswipe.js"></script> -->
    <!-- <script type="text/javascript" src="../shared/js/html5.js"></script> -->
    <script type="text/javascript" src="../shared/js/iscroll.js"></script>
    <script type="text/javascript" src="../shared/js/jqswipe.js"></script>
</head>

<body>
    <div id="ipad_div_menu">
        <div class="sonar-wrappernative">
            <div class="sonar-emitter">
                <div class="sonar-wave"></div>
                <div class="sonar-wave1"></div>
            </div>
        </div>
        <img src="./media/images/VeevaMenu.png" class="ipad_image_menu">
        <div id="ipad_button_menu" class="ipad_native_button"></div>
        <div id="ipad_button_marker" class="ipad_native_button"></div>
        <div id="ipad_button_back" class="ipad_native_button"></div>
        <div id="ipad_button_blue" class="ipad_native_button"></div>
        <div id="ipad_button_white" class="ipad_native_button"></div>
        <div id="ipad_button_red" class="ipad_native_button"></div>
    </div>
    <div class="container">
        <div id="touchCursor" style="display: none;"></div>
        <div class="page_content" slideId="21">
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <div id="isi_popup" class="popup" style="left: 0px; opacity: 1; display: none;">
                <div id="isi_overlay" class="popup_overlay popup_overlay_21"></div>
                <div id="isi_bg" class="popup_bg_s21">
                    <div class="sonar-wrapper21">
                        <div class="sonar-emitter">
                            <div class="sonar-wave"></div>
                            <div class="sonar-wave1"></div>
                        </div>
                    </div>
                    <div id="isi_content_wrapper" class="popup_content_wrapper popup_scroll_props">
                        <div id="isi_content" class="popup_scroll_content">
                            <div class="indication_wrapper">
                                <p class="isi_header">Indication</p>
                                <section class="indi_section_1">
                                    <p class="isi_text">PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) is indicated
                                        for the treatment of adult patients with prostate-specific membrane antigen
                                        <nobr>(PSMA)-positive</nobr> metastatic castration-resistant prostate cancer
                                        (mCRPC) who have been treated with androgen receptor pathway inhibition (ARPI)
                                        therapy, and
                                    </p>
                                    <ul class="isi_list">
                                        <li>are considered appropriate to delay taxane-based chemotherapy, or</li>
                                        <li>have received prior taxane-based chemotherapy</li>
                                    </ul>
                                </section>
                            </div>
                            <div class="isi_wrapper isi_wrapper_21">
                                <p class="isi_header">IMPORTANT SAFETY INFORMATION</p>
                                <section class="isi_section_1">
                                    <p class="isi_sub_header">Risk From Radiation Exposure</p>
                                    <p class="isi_text">PLUVICTO contributes to a patient’s long-term cumulative
                                        radiation exposure, which is associated with an increased risk for cancer.</p>
                                    <p class="isi_text">Minimize radiation exposure to patients, medical personnel, and
                                        others during and after treatment with PLUVICTO consistent with institutional
                                        practices, patient treatment procedures, Nuclear Regulatory Commission
                                        patient-release guidance, and instructions to the patient for follow-up
                                        radiation protection.</p>
                                    <p class="isi_text">Ensure patients increase oral fluid intake and advise them to
                                        void as often as possible to reduce bladder radiation.</p>
                                    <p class="isi_text">To minimize radiation exposure to others, advise patients to
                                        limit close contact (less than <nobr>3 feet)</nobr> with household contacts for
                                        2 days or with children and pregnant women for <nobr>7 days</nobr>, to refrain
                                        from sexual activity for 7 days, and to sleep in a separate bedroom from
                                        household contacts for 3 days, from children for 7 days, or from pregnant women
                                        for <nobr>15 days.</nobr>
                                    </p>

                                </section>

                                <section class="isi_section_2">
                                    <p class="isi_sub_header">Myelosuppression</p>
                                    <p class="isi_text">PLUVICTO can cause severe and life-threatening myelosuppression.
                                        In the PSMAfore study, grade 3 or 4 decreased hemoglobin (7%), decreased
                                        leukocytes (4.4%), decreased neutrophils (3.5%), and decreased platelets (2.7%)
                                        occurred in patients treated with PLUVICTO. One death occurred due to bone
                                        marrow failure during long-term follow-up in a patient who received PLUVICTO. In
                                        the VISION study, 4 myelosuppression-related deaths occurred. </p>
                                    <p class="isi_text">Perform complete blood counts before and during treatment with
                                        PLUVICTO. Withhold, reduce dose, or permanently discontinue PLUVICTO based on
                                        severity of myelosuppression.</p>

                                </section>

                                <section class="isi_section_3">
                                    <p class="isi_sub_header">Renal Toxicity</p>
                                    <p class="isi_text">PLUVICTO can cause severe renal toxicity. In the PSMAfore study,
                                        grade 3 or 4 acute kidney injury (1.3%) occurred in patients treated with
                                        PLUVICTO.</p>
                                    <p class="isi_text">Advise patients to remain well hydrated and to urinate
                                        frequently before and after administration of PLUVICTO. Perform kidney function
                                        laboratory tests, including serum creatinine and calculated creatinine clearance
                                        (CrCl), before and during treatment. Withhold, reduce dose, or permanently
                                        discontinue PLUVICTO based on severity of renal toxicity.</p>

                                </section>

                                <section class="isi_section_4">
                                    <p class="isi_sub_header">Embryo-Fetal Toxicity</p>
                                    <p class="isi_text">The safety and efficacy of PLUVICTO have not been established in
                                        females. Based on its mechanism of action, PLUVICTO can cause fetal harm. No
                                        animal studies using lutetium Lu 177 vipivotide tetraxetan have been conducted
                                        to evaluate its effect on female reproduction and embryo-fetal development;
                                        however, radioactive emissions, including those from PLUVICTO, can cause fetal
                                        harm. Advise males with female partners of reproductive potential to use
                                        effective contraception during treatment with PLUVICTO and for 14 weeks after
                                        the last dose.</p>


                                </section>

                                <section class="isi_section_4">
                                    <p class="isi_sub_header">Infertility</p>
                                    <p class="isi_text">The recommended cumulative dose of 44.4 GBq of PLUVICTO results
                                        in a <nobr>radiation-absorbed</nobr> dose to the testes within the range where
                                        PLUVICTO may cause temporary or permanent infertility.</p>


                                </section>

                                <section class="isi_section_4">
                                    <p class="isi_sub_header">Adverse Reactions and Laboratory Abnormalities</p>
                                    <p class="isi_text">In the pooled safety population for the PSMAfore and VISION
                                        studies (N=756), the most common (≥20%) adverse reactions, including laboratory
                                        abnormalities, were decreased lymphocytes (83%), decreased hemoglobin (65%),
                                        fatigue (49%), dry mouth (46%), decreased platelets (40%), decreased estimated
                                        glomerular filtration rate (37%), nausea (35%), decreased neutrophils (31%),
                                        decreased calcium (29%), decreased sodium (27%), increased aspartate
                                        aminotransferase (26%), increased alkaline phosphatase (24%), arthralgia (22%),
                                        decreased appetite (21%), increased potassium (21%), constipation (21%), and
                                        back pain (21%).</p>

                                    <p><b>
                                            Please see full <a
                                                href="https://www.novartis.com/us-en/sites/novartis_us/files/pluvicto.pdf">Prescribing
                                                Information</a>.</b>

                                    </p>
                                    <div>
                                        <img id="novartisLogo" src="../shared/media/images/Novartis_logo_VM_page.png"
                                            alt="">
                                        <p></p>


                                        <img id="pluvicto_logo" src="../shared/media/images/brand_logo1.png" alt="">

                                    </div>

                                    <p class="isi_text_section"><span class="fi_rst"><b>Novartis Pharmaceuticals
                                                Corporation</b><br>East Hanover, New Jersey 07936-1080</span> <span
                                            class="isi_year">©2025 Novartis</span><span
                                            class="isi_date">6/25</span><span class="isi_contentid">FA-11383644</span>
                                    </p>

                                </section>
                            </div>
                        </div>
                    </div>
                    <div id="isi_close" class="popup_close btn" data-km="" data-trng="22">
                        <svg viewBox="0 0 24 24" class="icon_svg popup_close_svg">
                            <use href="#svg_icons_menu_close"></use>
                        </svg>
                    </div>
                </div>
            </div>
            <video class="speaker_img_s21" playinline>
                <source src="./media/video/VO_21.mp4" type="video/mp4">
            </video>
            <img src="./media/images/txt/txt-21.png" class="message_img_s21">
        </div>
        <div class="page_content" slideId="22">
            <p class="txt_footer_1">
                This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.
            </p>
            <video class="speaker_img_s22" playinline>
                <source src="./media/video/VO_22.mp4" type="video/mp4">
            </video>
            <img src="./media/images/txt/txt-22.png" class="message_img_s22">
            <img src="./media/images/btn_positive.png" class="btn_positive_s22 ipad_button_s22">
            <img src="./media/images/btn_netural.png" class="btn_netural_s22 ipad_button_s22">
            <img src="./media/images/btn_negative.png" class="btn_negative_s22 ipad_button_s22">
            <img src="./media/images/nextBtn.png" class="button_img_s22 btn" data-km="" data-trng="23">
        </div>
        <div class="page_content" slideId="23">
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <video class="speaker_img_s23" playinline>
                <source src="./media/video/VO_23.mp4" type="video/mp4">
            </video>
            <img src="./media/images/txt/txt-23.png" class="message_img_s23">
            <div class="sonar-wrapper1">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div>
            <div class="menu_button_img_s23 btn" data-km="" data-trng="24"></div>
        </div>
        <div class="page_content" slideId="24">
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <video class="speaker_img_s24" playinline>
                <source src="./media/video/VO_24.mp4" type="video/mp4">
            </video>
            <img src="./media/images/txt/txt-24.png" class="message_img_s24">
            <div class="sonar-wrapper1">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div>
            <div class="popbutton_button_img_s24 btn" data-km="" data-trng="25"></div>
            <div class="animation_button_img_s24 btn" data-km="" data-trng="25"></div>
            <div class="toggle_button_img_s24 btn" data-km="" data-trng="25"></div>
            <div class="video_button_img_s24 btn" data-km="" data-trng="25"></div>
            <div class="zoomin_button_img_s24 btn" data-km="" data-trng="25"></div>
        </div>
        <div class="page_content" slideId="25">
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <video class="speaker_img_s25" playinline>
                <source src="./media/video/VO_25.mp4" type="video/mp4">
            </video>
            <img src="./media/images/txt/txt-25.png" class="message_img_s25">
            <img src="./media/images/Slide25Modal.png" class="model_img_s25">
            <div class="sonar-wrapper1">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div>
            <div class="toggle_button_img_s25 btn" data-km="" data-trng="26"></div>
        </div>
        <div class="page_content" slideId="26">
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <video class="speaker_img_s26" playinline>
                <source src="./media/video/VO_26.mp4" type="video/mp4">
            </video>
            <img src="./media/images/txt/txt-26.png" class="message_img_s26">
            <div class="sonar-wrapper1">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div>
            <div class="popbutton_button_img_s26 btn" data-km="" data-trng="27"></div>
        </div>
        <div class="page_content" slideId="27">
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <video class="speaker_img_s27" playinline>
                <source src="./media/video/VO_27.mp4" type="video/mp4">
            </video>
            <img src="./media/images/txt/txt-27.png" class="message_img_s27">
            <div class="sonar-wrapper1">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div>
            <div class="ppJames_button_img_s27 btn" data-km="" data-trng="28"></div>
        </div>
        <div class="page_content" slideId="28">
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <video class="speaker_img_s28" playinline>
                <source src="./media/video/VO_28.mp4" type="video/mp4">
            </video>
            <img src="./media/images/txt/txt-28.png" class="message_img_s28">
            <div class="sonar-wrapper1">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div>
            <div class="videobutton_button_img_s28 btn" data-km="" data-trng="29"></div>
        </div>
        <div class="page_content" slideId="29">
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <video class="speaker_img_s29" playinline>
                <source src="./media/video/VO_29.mp4" type="video/mp4">
            </video>
            <img src="./media/images/txt/txt-29.png" class="message_img_s29">
            <div class="video_thumbnail preview_btn videobutton_button_img" data-type="video"
                data-target="video_sample.mp4" pop-modal="pop29">
            </div>
            <div id="video_popup" class="popup" style="left: 0px; opacity: 1; display: none;">
                <video id="resource_video" class="" controls="" style="">
                    <source id="video_src" src="../shared/media/videos/video_sample.mp4" type="video/mp4">
                </video>
                <div id="video_close_29" class="popup_close popup_close_btn video_popup_close_btn btn" data-km=""
                    data-trng="30">
                    <svg viewBox="0 0 24 24" class="icon_svg popup_close_svg">
                        <use href="#svg_icons_menu_close"></use>
                    </svg>
                </div>
            </div>
        </div>
        <div class="page_content" slideId="30">
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <video class="speaker_img_s30" playinline>
                <source src="./media/video/VO_30.mp4" type="video/mp4">
            </video>
            <img src="./media/images/txt/txt-30.png" class="message_img_s30">
            <div class="sonar-wrapper1">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div>
            <div class="enlarge_button_img_s30 btn" data-km="" data-trng="31"></div>
        </div>
        <div class="page_content" slideId="31">
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <video class="speaker_img_s31" playinline>
                <source src="./media/video/VO_31.mp4" type="video/mp4">
            </video>
            <img src="./media/images/txt/txt-31.png" class="message_img_s31">
            <div class="container">
                <img src="./media/images/Slide31Modal.png" class="modal_img_s31">
            </div>
            <div class="sonar-wrapper1">
                <div class="sonar-emitter">
                    <div class="sonar-wave"></div>
                    <div class="sonar-wave1"></div>
                </div>
            </div>
            <div class="cancle_button_img_s31 btn" data-km="" data-trng="32"></div>
        </div>
        <div class="page_content" slideId="32">
            <p class="txt_footer_1">This information is for internal use only and is not to be left with, detailed from,
                or
                shown to anyone outside Novartis Pharmaceuticals Corporation.</p>
            <video class="speaker_img_s32" playinline>
                <source src="./media/video/VO_32.mp4" type="video/mp4">
            </video>
            <img src="./media/images/txt/txt-32.png" class="message_img_s32">
            <img src="./media/images/nextBtn.png" class="button_img_s32 btn" data-km="" data-trng="33">
        </div>
    </div>
</body>
<script type="text/javascript" src="./js/script.js"></script>

</html>